Simplex Trading’s Organogenesis Holdings ORGO Stock Holding History

Simplex Trading’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.7K	Buy	5,625 +1,130	+25%	+$2.76K	﹤0.01%	7434
2026 Q1	$10.7K	Sell	4,495 -7,121	-61%	-$24.7K	﹤0.01%	7310
2025 Q4	$60.2K	Buy	+11,616	New	+$56.3K	﹤0.01%	5494
2024 Q3	–	Sell	-1,823	Closed	-$5.11K	–	9268
2024 Q2	$5K	Buy	+1,823	New	+$4.89K	﹤0.01%	7889
2023 Q2	–	Sell	-7,328	Closed	-$21.7K	–	9666
2023 Q1	$15K	Buy	7,328 +4,949	+208%	+$12.2K	﹤0.01%	7200
2022 Q4	$6K	Buy	2,379 +2,107	+775%	+$6.15K	﹤0.01%	7950
2022 Q3	$0	Buy	+272	New	+$1.23K	﹤0.01%	10615
2022 Q2	–	Sell	-10,863	Closed	-$66.9K	–	10766
2022 Q1	$82K	Buy	10,863 +10,261	+1,704%	+$79.4K	﹤0.01%	6441
2021 Q4	$5K	Buy	+602	New	+$6.39K	﹤0.01%	9540
2021 Q2	–	Sell	-1,713	Closed	-$31.9K	–	10514
2021 Q1	$31K	Buy	+1,713	New	+$23.2K	﹤0.01%	7091

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Simplex Trading's ORGO Position: Q2 2026 in Review

Simplex Trading increased its Organogenesis Holdings (ORGO) stake by 25% in Q2 2026, buying an estimated $2.76K and bringing the position to 5,625 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7434.

Simplex Trading first reported a position in ORGO in Q1 2021 and has held it in 10 quarters since. The position peaked at $82K in Q1 2022. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Simplex Trading held 5,625 shares of Organogenesis Holdings worth $13.7K as of Q2 2026.
Simplex Trading bought 1,130 Organogenesis Holdings shares in Q2 2026, an estimated $2.76K.
Organogenesis Holdings made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7434 holding.
Simplex Trading first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 10 quarters since.
Simplex Trading's Organogenesis Holdings position peaked at $82K in Q1 2022.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.